Abiomed Company Profile (NASDAQ:ABMD)

About Abiomed

Abiomed logoABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABMD
  • CUSIP: 00365410
Key Metrics:
  • Previous Close: $125.27
  • 50 Day Moving Average: $124.93
  • 200 Day Moving Average: $111.64
  • 52-Week Range: $42,811,000.00 - $67.81
  • Trailing P/E Ratio: 132.82
  • Foreward P/E Ratio: 69.36
  • P/E Growth: 3.96
  • Market Cap: $5.34B
  • Outstanding Shares: 42,811,000
  • Beta: 0.75
  • Net Margins: 11.75%
  • Return on Equity: 11.86%
  • Return on Assets: 10.43%
  • Current Ratio: 6.95%
  • Quick Ratio: 6.28%
Additional Links:
Companies Related to Abiomed:

Analyst Ratings

Consensus Ratings for Abiomed (NASDAQ:ABMD) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $116.67 (6.55% downside)

Analysts' Ratings History for Abiomed (NASDAQ:ABMD)
DateFirmActionRatingPrice TargetDetails
9/28/2016Leerink SwannReiterated RatingOutperform$125.00View Rating Details
8/9/2016Jefferies GroupBoost Price TargetBuy$130.00 -> $145.00View Rating Details
4/10/2016Benchmark Co.Reiterated RatingBuy$145.00View Rating Details
2/5/2016Piper Jaffray Cos.Reiterated RatingHold$75.00 -> $90.00View Rating Details
2/5/2016BTIG ResearchReiterated RatingBuy$110.00View Rating Details
10/30/2015Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$85.00View Rating Details
10/29/2015Sterne Agee CRTReiterated RatingBuyView Rating Details
8/17/2015CRT CapitalInitiated CoverageBuyView Rating Details
8/14/2015StephensReiterated RatingOverweight$103.00 -> $128.00View Rating Details
8/5/2015Northland SecuritiesBoost Price TargetMarket Perform$60.00 -> $80.00View Rating Details
(Data available from 10/22/2014 forward)


Earnings History for Abiomed (NASDAQ:ABMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q117$0.23$0.29$97.23 million$103.00 millionViewListenView Earnings Details
5/3/2016Q416$0.19$0.24$90.52 million$94.00 millionViewN/AView Earnings Details
2/4/2016Q316$0.15$0.23$80.04 million$85.80 millionViewListenView Earnings Details
10/29/2015Q2$0.13$0.17$74.56 million$76.30 millionViewListenView Earnings Details
8/4/2015Q116$0.08$0.20$66.27 million$73.40 millionViewN/AView Earnings Details
5/5/2015Q415$0.12$0.28$62.55 million$67.60 millionViewN/AView Earnings Details
1/28/2015Q315$0.04$0.30$53.20 million$62.00 millionViewN/AView Earnings Details
10/30/2014Q215$0.02$0.03$48.80 million$51.80 millionViewN/AView Earnings Details
7/31/2014Q115$0.01($0.04)$297.10 million$48.80 millionViewN/AView Earnings Details
5/1/2014Q414$0.08$0.09$50.93 million$50.40 millionViewN/AView Earnings Details
1/31/2014Q314$0.05$0.11$46.00 million$46.20 millionViewN/AView Earnings Details
11/6/2013Q214$0.03$0.03$43.75 million$44.30 millionViewN/AView Earnings Details
8/1/2013Q1 2014$0.06($0.04)$42.93 million$42.70 millionViewN/AView Earnings Details
5/2/2013Q4 2013$0.08$0.09$41.87 million$43.70 millionViewN/AView Earnings Details
2/6/2013Q3 2013$0.07$0.07$38.04 million$38.30 millionViewN/AView Earnings Details
11/1/2012Q213$0.05$0.20$37.47 million$37.40 millionViewN/AView Earnings Details
8/2/2012$0.10$0.16ViewN/AView Earnings Details
5/16/2012$0.07$0.07ViewN/AView Earnings Details
2/3/2012($0.01)$0.07ViewN/AView Earnings Details
11/3/2011($0.09)$0.02ViewN/AView Earnings Details
8/4/2011($0.06)($0.03)ViewN/AView Earnings Details
5/18/2011($0.04)($0.05)ViewN/AView Earnings Details
2/3/2011($0.09)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Abiomed (NASDAQ:ABMD)
Current Year EPS Consensus Estimate: $1.17 EPS
Next Year EPS Consensus Estimate: $1.80 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.12$0.20$0.16
Q2 20163$0.22$0.25$0.23
Q3 20164$0.19$0.28$0.25
Q4 20164$0.25$0.34$0.29
Q1 20176$0.20$0.29$0.24
Q2 20173$0.22$0.24$0.23
Q3 20173$0.29$0.31$0.30
Q4 20172$0.32$0.33$0.33
Q1 20182$0.37$0.38$0.38
Q2 20182$0.29$0.34$0.32
Q3 20182$0.39$0.45$0.42
Q4 20182$0.42$0.51$0.47
Q1 20191$0.41$0.41$0.41
(Data provided by Zacks Investment Research)


Dividend History for Abiomed (NASDAQ:ABMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Abiomed (NASDAQ:ABMD)
Insider Ownership Percentage: 10.00%
Institutional Ownership Percentage: 93.43%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Michael R MinogueCEOSell28,039$127.07$3,562,915.73View SEC Filing  
9/21/2016Michael R MinogueCEOSell5,034$127.07$639,670.38View SEC Filing  
9/19/2016Michael R MinogueCEOSell58,710$127.00$7,456,170.00View SEC Filing  
8/15/2016Dorothy E PuhyDirectorSell5,160$123.94$639,530.40View SEC Filing  
8/10/2016Dorothy E PuhyDirectorSell3,900$122.31$477,009.00View SEC Filing  
8/8/2016Michael G HowleyVPSell17,853$119.20$2,128,077.60View SEC Filing  
8/1/2016Henri A TermeerDirectorSell25,866$118.70$3,070,294.20View SEC Filing  
6/29/2016Michael G HowleyVPSell10,000$106.58$1,065,800.00View SEC Filing  
6/7/2016Andrew J GreenfieldVPSell9,000$104.16$937,440.00View SEC Filing  
5/23/2016David M WeberCOOSell4,342$96.97$421,043.74View SEC Filing  
5/16/2016David M WeberCOOSell5,604$94.56$529,914.24View SEC Filing  
5/6/2016David M WeberCOOSell2,145$93.82$201,243.90View SEC Filing  
5/5/2016David M WeberCOOSell52,000$95.27$4,954,040.00View SEC Filing  
5/5/2016Paul ThomasDirectorSell7,500$95.14$713,550.00View SEC Filing  
4/18/2016Andrew J GreenfieldVPSell10,000$99.10$991,000.00View SEC Filing  
4/13/2016Michael G HowleyVPSell9,800$98.64$966,672.00View SEC Filing  
4/8/2016Michael G HowleyVPSell200$98.80$19,760.00View SEC Filing  
4/1/2016Dorothy E PuhyDirectorSell10,000$95.02$950,200.00View SEC Filing  
3/31/2016Andrew J GreenfieldVPSell15,000$94.11$1,411,650.00View SEC Filing  
3/24/2016David M WeberCOOSell5,235$89.93$470,783.55View SEC Filing  
3/22/2016Andrew J GreenfieldVPSell24,800$89.06$2,208,688.00View SEC Filing  
3/22/2016Dorothy E PuhyDirectorSell10,000$90.30$903,000.00View SEC Filing  
3/21/2016Andrew J GreenfieldVPSell19,572$89.07$1,743,278.04View SEC Filing  
3/10/2016Andrew J GreenfieldVPSell200$89.00$17,800.00View SEC Filing  
3/8/2016David M WeberCOOSell17,521$85.20$1,492,789.20View SEC Filing  
3/8/2016William J BoltSVPSell17,510$85.19$1,491,676.90View SEC Filing  
3/7/2016David M WeberCOOSell8,111$85.21$691,138.31View SEC Filing  
3/7/2016Dorothy E PuhyDirectorSell4,000$85.00$340,000.00View SEC Filing  
3/7/2016William J BoltSVPSell7,987$85.20$680,492.40View SEC Filing  
2/8/2016Dorothy E. PuhyDirectorSell4,000$80.47$321,880.00View SEC Filing  
8/19/2015Michael R. MinogueCEOSell146,800$104.87$15,394,916.00View SEC Filing  
8/17/2015Dorothy E PuhyDirectorSell2,580$103.91$268,087.80View SEC Filing  
8/14/2015Dorothy E PuhyDirectorSell2,580$105.27$271,596.60View SEC Filing  
7/17/2015Michael G HowleyVPSell21,295$70.00$1,490,650.00View SEC Filing  
6/15/2015Andrew J GreenfieldVPSell3,185$65.00$207,025.00View SEC Filing  
5/29/2015Martin P SutterDirectorBuy7,500$60.17$451,275.00View SEC Filing  
5/27/2015David M WeberCOOSell17,968$60.77$1,091,915.36View SEC Filing  
5/12/2015Michael G HowleyVPSell17,353$66.47$1,153,453.91View SEC Filing  
5/7/2015Andrew J GreenfieldVPSell3,500$71.00$248,500.00View SEC Filing  
5/7/2015Robert BowenCFOSell2,372$71.52$169,645.44View SEC Filing  
5/6/2015David M WeberCOOSell1,605$73.72$118,320.60View SEC Filing  
5/6/2015Michael R MinogueCEOSell8,840$73.12$646,380.80View SEC Filing  
5/6/2015William J BoltSVPSell1,750$74.27$129,972.50View SEC Filing  
3/23/2015David M WeberCOOSell3,765$71.08$267,616.20View SEC Filing  
10/31/2014Andrew J GreenfieldVPSell15,000$31.90$478,500.00View SEC Filing  
10/31/2014Michael R MinogueCEOSell164,000$31.14$5,106,960.00View SEC Filing  
7/28/2014Michael R MinogueCEOSell82,383$26.30$2,166,672.90View SEC Filing  
5/27/2014Andrew J GreenfieldVPSell7,026$21.10$148,248.60View SEC Filing  
5/27/2014David M WeberCOOSell10,172$21.11$214,730.92View SEC Filing  
5/27/2014Michael R MinogueCEOSell90,001$21.19$1,907,121.19View SEC Filing  
5/27/2014Robert BowenCFOSell6,820$21.11$143,970.20View SEC Filing  
5/27/2014William J BoltSVPSell8,029$21.10$169,411.90View SEC Filing  
5/15/2014David WeberCOOSell1,425$20.94$29,839.50View SEC Filing  
5/15/2014Michael HowleyVPSell1,267$20.94$26,530.98View SEC Filing  
5/15/2014Michael MinogueCEOSell4,433$20.94$92,827.02View SEC Filing  
5/15/2014William BoltSVPSell1,110$20.94$23,243.40View SEC Filing  
1/10/2014Robert BowenCFOSell37,500$30.00$1,125,000.00View SEC Filing  
9/3/2013David WeberCOOSell6,500$24.00$156,000.00View SEC Filing  
9/3/2013William BoltSVPSell20,000$24.00$480,000.00View SEC Filing  
8/14/2013William BoltSVPSell21,534$23.35$502,818.90View SEC Filing  
8/13/2013David WeberCOOSell4,400$23.00$101,200.00View SEC Filing  
8/13/2013Michael HowleyVPSell8,400$23.00$193,200.00View SEC Filing  
8/5/2013David WeberCOOSell7,100$22.90$162,590.00View SEC Filing  
8/5/2013Michael HowleyVPSell1,600$23.03$36,848.00View SEC Filing  
8/5/2013Robert BowenCFOSell2,235$22.64$50,600.40View SEC Filing  
8/5/2013W Gerald AustenDirectorSell8,000$22.85$182,800.00View SEC Filing  
8/5/2013William BoltSVPSell20,166$22.70$457,768.20View SEC Filing  
7/31/2013Michael R MinogueCEOSell36,500$25.04$913,960.00View SEC Filing  
7/17/2013Michael G HowleyVPSell10,000$24.45$244,500.00View SEC Filing  
7/15/2013Robert BowenCFOSell40,786$23.50$958,471.00View SEC Filing  
7/11/2013Robert BowenCFOSell1,499$23.50$35,226.50View SEC Filing  
6/4/2013David M WeberCOOSell6,519$21.20$138,202.80View SEC Filing  
6/4/2013Michael G HowleyVPSell3,881$21.20$82,277.20View SEC Filing  
6/4/2013Michael R MinogueCEOSell17,667$21.23$375,070.41View SEC Filing  
6/4/2013Robert BowenCFOSell5,298$21.20$112,317.60View SEC Filing  
6/4/2013William J BoltSVPSell4,967$21.20$105,300.40View SEC Filing  
5/29/2013Michael R MinogueCEOSell58,833$21.83$1,284,324.39View SEC Filing  
5/28/2013David M WeberCOOSell6,018$22.18$133,479.24View SEC Filing  
5/28/2013Michael G HowleyVPSell5,476$22.18$121,457.68View SEC Filing  
5/28/2013Robert BowenCFOSell5,102$22.18$113,162.36View SEC Filing  
5/28/2013William J BoltSVPSell4,629$22.18$102,671.22View SEC Filing  
5/23/2013Andrew J GreenfieldVPSell1,666$21.63$36,035.58View SEC Filing  
5/23/2013Michael R MinogueCEOSell5,666$21.62$122,498.92View SEC Filing  
5/17/2013Robert BowenCFOSell2,715$23.50$63,802.50View SEC Filing  
5/9/2013Michael R MinogueCEOSell20,000$21.00$420,000.00View SEC Filing  
5/7/2013Henri A TermeerDirectorBuy100,000$19.86$1,986,000.00View SEC Filing  
2/25/2013Henri A TermeerDirectorBuy100,000$14.98$1,498,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Abiomed (NASDAQ:ABMD)
News IconJPMorgan Chase & Co. Acquires 1,150 Shares of Abiomed Inc ... - DailyQuint (NASDAQ:ABMD)
dailyquint.com - October 21 at 11:58 AM
News IconABIOMED, Inc. (NASDAQ:ABMD) Updated Broker Price Targets ... - The De Soto Edge (NASDAQ:ABMD)
www.desotoedge.com - October 20 at 3:13 PM
News IconPumping the Brakes, Stock Gapping Downward: ABIOMED, Inc. (NASDAQ:ABMD) - CSZ News (NASDAQ:ABMD)
cincysportszone.com - October 20 at 3:13 PM
News IconAnalysts Projecting Steady Growth for ABIOMED, Inc. (NASDAQ:ABMD) - CSZ News (NASDAQ:ABMD)
cincysportszone.com - October 18 at 3:15 PM
News IconShort Interest Change: Abiomed Incorporated (NASDAQ:ABMD) Short Interest Decreased By 11.86% - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - October 18 at 8:00 AM
News IconShares Worth Watching: ABIOMED, Inc. (NASDAQ:ABMD) - Recall News (NASDAQ:ABMD)
www.automobile-recalls.net - October 17 at 8:02 AM
News IconLatest Analyst Ratings For ABIOMED, Inc. (NASDAQ:ABMD) - The ... - The De Soto Edge (NASDAQ:ABMD)
www.desotoedge.com - October 16 at 3:15 PM
News Icon252 Shares of Abiomed Inc. (ABMD) are sold by Retirement Systems of Alabama - DailyQuint (NASDAQ:ABMD)
dailyquint.com - October 15 at 8:02 AM
News IconWhat are Analysts Expecting for ABIOMED, Inc. (NASDAQ:ABMD) Earnings? - CSZ News (NASDAQ:ABMD)
cincysportszone.com - October 13 at 3:15 PM
fidaily.com logoEagle Asset Management Inc Sells A Lot More ABIOMED, Inc. (ABMD) Stock (NASDAQ:ABMD)
www.fidaily.com - October 12 at 8:21 PM
News IconIn it for the Long Haul: Update on ABIOMED, Inc. (NASDAQ:ABMD) - CSZ News (NASDAQ:ABMD)
cincysportszone.com - October 12 at 3:11 PM
zacks.com logoBaxter (BAX): Portfolio Strong, Cyclophosphamide Sales Low (NASDAQ:ABMD)
www.zacks.com - October 7 at 8:02 AM
globenewswire.com logoAbiomed Second Quarter Fiscal 2017 Earnings and Conference Call Notification (NASDAQ:ABMD)
globenewswire.com - October 7 at 8:02 AM
finance.yahoo.com logoHenry Schein Well Poised on Strategic Buyouts, Pricing Hurts (NASDAQ:ABMD)
finance.yahoo.com - October 7 at 8:02 AM
News IconReg Filings: Cupps Capital Management LLC Has Lowered Position in Abiomed INC (ABMD) by $7.35 Million - Chester News (NASDAQ:ABMD)
www.chesterindependent.com - October 4 at 8:02 AM
seekingalpha.com logoAbiomed: Excellent Recent Results, But Stay Cautious - Seeking Alpha (NASDAQ:ABMD)
seekingalpha.com - October 3 at 3:15 PM
News IconAnalyst Target Update & Review on ABIOMED, Inc. (NASDAQ:ABMD) - Recall News (NASDAQ:ABMD)
www.automobile-recalls.net - October 3 at 8:02 AM
seekingalpha.com logoAbiomed's heart pumps approved in Japan - Seeking Alpha (NASDAQ:ABMD)
seekingalpha.com - September 29 at 8:01 AM
biz.yahoo.com logoABIOMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exh (NASDAQ:ABMD)
biz.yahoo.com - September 29 at 8:01 AM
seekingalpha.com logoAbiomed's heart pumps approved in Japan (NASDAQ:ABMD)
seekingalpha.com - September 28 at 6:34 PM
4-traders.com logoAbiomed : Impella 2.5and Impella 5.0 Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare (NASDAQ:ABMD)
www.4-traders.com - September 28 at 3:14 PM
finance.yahoo.com logoAbiomed: Heart Pumps Receive Regulatory Approval in Japan (NASDAQ:ABMD)
finance.yahoo.com - September 28 at 3:14 PM
globenewswire.com logoFirst ever percutaneous heart pump approval in Japan (NASDAQ:ABMD)
globenewswire.com - September 27 at 3:16 PM
feeds.reuters.com logoBRIEF-Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare (NASDAQ:ABMD)
feeds.reuters.com - September 27 at 8:44 AM
investornewswire.com logoAnalysts Expect ABIOMED, Inc. (NASDAQ:ABMD) To Post EPS Of $0.36 - Investor Newswire (NASDAQ:ABMD)
www.investornewswire.com - September 23 at 8:03 AM
News IconAnalyst Views and Growth Review for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 23 at 8:03 AM
mysmartrend.com logoABIOMED Has Returned 50.7% Since SmarTrend Recommendation (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - September 22 at 3:15 PM
News IconConsensus Take: ABIOMED, Inc. (NASDAQ:ABMD) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 21 at 3:22 PM
nasdaq.com logoABMD Crosses Above Average Analyst Target - Nasdaq (NASDAQ:ABMD)
www.nasdaq.com - September 20 at 9:01 AM
rttnews.com logoAbiomed Inc. (ABMD) Has Risen To A New High For The Year (NASDAQ:ABMD)
www.rttnews.com - September 19 at 4:05 PM
fidaily.com logoMacquarie Group Ltd Decreases Its Ownership in ABIOMED, Inc. (ABMD) Stock Last Quarter - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - September 15 at 3:15 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: ABIOMED, Inc. (NASDAQ:ABMD) - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 15 at 3:15 PM
News IconAnalyst Projections and Growth Recap for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 15 at 3:15 PM
mysmartrend.com logo40.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - September 15 at 12:07 PM
capitalcube.com logoABIOMED, Inc. – Value Analysis (NASDAQ:ABMD) : September 13, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 13 at 3:15 PM
capitalcube.com logoABIOMED, Inc. breached its 50 day moving average in a Bearish Manner : ABMD-US : September 12, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 12 at 3:16 PM
News IconAnalysts Place ABIOMED, Inc. (NASDAQ:ABMD) Under the Lens of the Microscope - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 12 at 8:02 AM
News IconInstitutional Investors Have Decreased Positions in ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 9 at 8:03 AM
News IconABIOMED, Inc. (NASDAQ:ABMD): What is the Sell-side Making of this Stock? - National Daily Press (NASDAQ:ABMD)
www.nationaldailypress.com - September 9 at 8:03 AM
News IconStreet Projections and Growth Recap for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 8 at 3:15 PM
News IconStock Sliding Down Over the Last Month: ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 8 at 12:14 PM
capitalcube.com logoETF’s with exposure to ABIOMED, Inc. : September 7, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 7 at 12:12 PM
News IconAnalysts are Chiming in on ABIOMED, Inc. (NASDAQ:ABMD ... - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 6 at 3:13 PM
News IconInstitutions Have Decreased Positions in ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 2 at 5:49 AM
mysmartrend.com logo41.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - August 31 at 8:01 AM
News IconStock Up Over the Past Five Trading Days: ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 29 at 8:33 PM
News IconWhat Does the Consensus Have to Say About ABIOMED, Inc. (NASDAQ:ABMD)? Crowd & Analysts Chime in - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 29 at 3:25 PM
News IconStreet Views and Growth Projections for ABIOMED, Inc. (NASDAQ ... - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 23 at 8:35 PM
mysmartrend.com logoABIOMED Up 43.3% Since SmarTrend Uptrend Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - August 23 at 3:13 PM
capitalcube.com logoETF’s with exposure to ABIOMED, Inc. : August 23, 2016 (NASDAQ:ABMD)
www.capitalcube.com - August 23 at 3:13 PM


Abiomed (NASDAQ:ABMD) Chart for Saturday, October, 22, 2016

Last Updated on 10/22/2016 by MarketBeat.com Staff